| Primary |
| Pain |
34.4% |
| Product Used For Unknown Indication |
24.8% |
| Back Pain |
9.3% |
| Fibromyalgia |
4.3% |
| Breakthrough Pain |
3.6% |
| Depression |
3.1% |
| Anxiety |
2.4% |
| Sleep Disorder |
1.9% |
| Neuralgia |
1.8% |
| Hypertension |
1.7% |
| Blood Pressure |
1.7% |
| Neuropathy Peripheral |
1.6% |
| Diabetes Mellitus |
1.4% |
| Intervertebral Disc Degeneration |
1.3% |
| Arthralgia |
1.2% |
| Arthritis |
1.2% |
| Nausea |
1.2% |
| Rheumatoid Arthritis |
1.1% |
| Migraine |
1.1% |
| Complex Regional Pain Syndrome |
1.0% |
|
| Wrong Technique In Drug Usage Process |
51.5% |
| Product Quality Issue |
14.5% |
| Withdrawal Syndrome |
5.5% |
| Drug Dose Omission |
5.1% |
| Pain |
3.4% |
| Inappropriate Schedule Of Drug Administration |
3.0% |
| Product Adhesion Issue |
1.9% |
| Death |
1.8% |
| Vomiting |
1.6% |
| Weight Decreased |
1.6% |
| Drug Ineffective |
1.4% |
| Treatment Noncompliance |
1.4% |
| Therapeutic Response Decreased |
1.2% |
| Product Packaging Quantity Issue |
1.1% |
| Drug Administered At Inappropriate Site |
0.9% |
| Intentional Drug Misuse |
0.9% |
| Toxicity To Various Agents |
0.9% |
| Incorrect Drug Administration Duration |
0.8% |
| Overdose |
0.8% |
| Surgery |
0.8% |
|
| Secondary |
| Pain |
32.7% |
| Product Used For Unknown Indication |
17.6% |
| Back Pain |
11.0% |
| Fibromyalgia |
8.2% |
| Breakthrough Pain |
3.2% |
| Neuropathy Peripheral |
3.2% |
| Intervertebral Disc Degeneration |
2.8% |
| Depression |
2.5% |
| Arthritis |
2.2% |
| Pain In Extremity |
1.9% |
| Muscle Spasms |
1.7% |
| Neck Pain |
1.6% |
| Rheumatoid Arthritis |
1.5% |
| Sleep Disorder |
1.5% |
| Lyme Disease |
1.5% |
| Blood Pressure |
1.4% |
| Anxiety |
1.4% |
| Neuralgia |
1.4% |
| Complex Regional Pain Syndrome |
1.4% |
| Hypertension |
1.3% |
|
| Wrong Technique In Drug Usage Process |
54.7% |
| Product Quality Issue |
11.5% |
| Withdrawal Syndrome |
4.5% |
| Vomiting |
3.4% |
| Weight Decreased |
3.0% |
| Pain |
2.8% |
| Drug Ineffective |
2.7% |
| Anxiety |
2.1% |
| Treatment Noncompliance |
1.8% |
| Surgery |
1.7% |
| Inappropriate Schedule Of Drug Administration |
1.5% |
| Product Adhesion Issue |
1.5% |
| Therapeutic Response Decreased |
1.4% |
| Skin Injury |
1.3% |
| Weight Increased |
1.2% |
| Pain In Extremity |
1.1% |
| Malaise |
1.0% |
| Somnolence |
1.0% |
| Toxicity To Various Agents |
1.0% |
| White Blood Cell Count Decreased |
1.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.8% |
| Pain |
17.0% |
| Rheumatoid Arthritis |
4.7% |
| Multiple Myeloma |
4.4% |
| Nausea |
4.0% |
| Depression |
3.8% |
| Drug Use For Unknown Indication |
3.8% |
| Hypertension |
3.2% |
| Plasma Cell Myeloma |
3.0% |
| Anxiety |
2.6% |
| Crohn's Disease |
2.5% |
| Breast Cancer |
2.4% |
| Metastases To Bone |
2.3% |
| Prophylaxis |
2.3% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Multiple Sclerosis |
2.1% |
| Constipation |
1.9% |
| Back Pain |
1.8% |
| Non-small Cell Lung Cancer |
1.6% |
| Hypothyroidism |
1.5% |
|
| Weight Decreased |
13.7% |
| Vomiting |
12.3% |
| Sepsis |
8.9% |
| Death |
7.5% |
| Urinary Tract Infection |
6.2% |
| Weight Increased |
5.5% |
| Pain |
4.8% |
| Wound |
4.8% |
| Pyrexia |
4.1% |
| Renal Failure Acute |
4.1% |
| Renal Failure |
3.4% |
| Wheezing |
3.4% |
| Wound Drainage |
3.4% |
| Nausea |
2.7% |
| Neoplasm Malignant |
2.7% |
| Pancytopenia |
2.7% |
| Pneumonia |
2.7% |
| Somnolence |
2.7% |
| Cardiac Failure Congestive |
2.1% |
| Drug Ineffective |
2.1% |
|
